BACKGROUND: Sleep apnoea, whether obstructive or central, is usually diagnosed by polysomnography. A simpler tool for screening high risk populations may be of value. METHODS: We compared a portable device using nasal pressure cannulae and a high-sensitivity pressure sensor (the ApneaLink) with our standard polysomnography technique for diagnosing sleep apnoea (using the Embletta device), in 67 patients being investigated for possible sleep apnoea. The patients' average age was 52.6, 79 per cent were male, the mean body mass index was 32.3, and the mean Epworth sleepiness score was 13.0. RESULTS: Twenty-five patients (45 per cent) were identified as having an apnoea-hypopnoea index of >15, as measured by the Embletta. The mean (standard deviation) apnoea-hypopnoea index was 21.5 +/- 23.0 as measured by the Embletta and 24.3 +/- 26.2 as measured by the ApneaLink. The sensitivity of the ApneaLink for an apnoea-hypopnoea index cut-off point of 15 was 92 per cent and the specificity was 96.7 per cent. The negative predictive value of the ApneaLink for an apnoea-hypopnoea index of < or = 15 was 94 per cent. CONCLUSIONS: The ApneaLink is a useful tool for screening patients thought to have possible sleep apnoea, and for selecting patients for definitive diagnostic testing.
BACKGROUND:Sleep apnoea, whether obstructive or central, is usually diagnosed by polysomnography. A simpler tool for screening high risk populations may be of value. METHODS: We compared a portable device using nasal pressure cannulae and a high-sensitivity pressure sensor (the ApneaLink) with our standard polysomnography technique for diagnosing sleep apnoea (using the Embletta device), in 67 patients being investigated for possible sleep apnoea. The patients' average age was 52.6, 79 per cent were male, the mean body mass index was 32.3, and the mean Epworth sleepiness score was 13.0. RESULTS: Twenty-five patients (45 per cent) were identified as having an apnoea-hypopnoea index of >15, as measured by the Embletta. The mean (standard deviation) apnoea-hypopnoea index was 21.5 +/- 23.0 as measured by the Embletta and 24.3 +/- 26.2 as measured by the ApneaLink. The sensitivity of the ApneaLink for an apnoea-hypopnoea index cut-off point of 15 was 92 per cent and the specificity was 96.7 per cent. The negative predictive value of the ApneaLink for an apnoea-hypopnoea index of < or = 15 was 94 per cent. CONCLUSIONS: The ApneaLink is a useful tool for screening patients thought to have possible sleep apnoea, and for selecting patients for definitive diagnostic testing.
Authors: Martin R Cowie; Holger Woehrle; Olaf Oldenburg; Thibaud Damy; Peter van der Meer; Erland Erdman; Marco Metra; Faiez Zannad; Jean-Noel Trochu; Lars Gullestad; Michael Fu; Michael Böhm; Angelo Auricchio; Patrick Levy Journal: Card Fail Rev Date: 2015-04
Authors: Kate E Crowley; Shantha M W Rajaratnam; Steven A Shea; Lawrence J Epstein; Charles A Czeisler; Steven W Lockley Journal: J Clin Sleep Med Date: 2013-02-01 Impact factor: 4.062
Authors: Holger Woehrle; Olaf Oldenburg; Michael Arzt; Andrea Graml; Erland Erdmann; Helmut Teschler; Karl Wegscheider Journal: BMC Cardiovasc Disord Date: 2014-04-09 Impact factor: 2.298
Authors: Michael Arzt; Marzena A Drzymalski; Sarah Ripfel; Sebastian Meindl; Alexander Biedermann; Melanie Durczok; Karoline Keller; Julian Mustroph; Sylvia Katz; Maria Tafelmeier; Simon Lebek; Bernhard Flörchinger; Daniele Camboni; Sigrid Wittmann; Johannes Backs; Christof Schmid; Lars S Maier; Stefan Wagner Journal: Antioxidants (Basel) Date: 2022-02-08
Authors: Oleg Y Chernyshev; David E McCarty; Douglas E Moul; Cesar Liendo; Gloria C Caldito; Sai K Munjampalli; Roger E Kelley; Andrew L Chesson Journal: Nat Sci Sleep Date: 2015-10-20